v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue:        
Total revenue $ 15,717 $ 500 $ 23,690 $ 500
Operating expenses:        
Cost of goods sold (including related party amounts of $866, $0, $1,354, and $0, respectively) 4,984 0 6,078 0
Research and development (including related party amounts of $582, $518, $1,245, and $1,245, respectively) 4,035 6,896 6,987 12,130
Selling, general and administrative (including related party amounts of $107, $114, $231, and $208, respectively) 54,312 8,944 95,416 16,902
Total operating expenses 63,331 15,840 108,481 29,032
Loss from operations (47,614) (15,340) (84,791) (28,532)
Other income, net 2,731 2,824 5,968 5,724
Net loss (44,883) (12,516) (78,823) (22,808)
Change in unrealized gains and losses on available-for-sale securities (118) (21) (266) (194)
Comprehensive loss $ (45,001) $ (12,537) $ (79,089) $ (23,002)
Net loss per share, Basic $ (0.46) $ (0.13) $ (0.8) $ (0.24)
Net loss per share, Diluted $ (0.46) $ (0.13) $ (0.8) $ (0.24)
Weighted- average common shares outstanding, basic 98,361,771 96,827,687 98,212,035 96,656,690
Weighted Average Number of Shares Outstanding, Diluted 98,361,771 96,827,687 98,212,035 96,656,690
Product revenue, net        
Revenue:        
Total revenue $ 12,800 $ 0 $ 20,563 $ 0
Revenue under collaboration agreements        
Revenue:        
Total revenue 2,594 500 2,804 500
Revenue under supply agreements        
Revenue:        
Total revenue $ 323 $ 0 $ 323 $ 0